Evercore ISI analyst Elizabeth Anderson downgraded Oak Street Health (OSH) to In Line from Outperform with a price target of $39, up from $25, after CVS Health (CVS) announced an agreement for its acquisition of Oak Street for $39 per share in cash.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH: